“Every Few Years, Wall Street Rediscovers the Word ‘Bubble’ — Here's What It Cost the People Who Listened Last Time” is the headline Keith Kohl is using to front Angel Publishing’s Technology and Opportunity promotion. The report is called “The AI Survivors: 3 Stocks Built to Outlast the Bubble Talk.”
The pitch says AI hype may come and go, but three companies supplying the hardware and infrastructure behind it could keep growing after the bubble talk fades. No deadline is stated in the promotion details here. We identify all three stocks below, with high confidence: 97/100 for the lead name, 94/100 for the second, and 98/100 for the third.
The clues they left
The promotion left behind three unusually sharp fingerprints. The lead company guided its next-quarter revenue to about $310 million while Wall Street expected roughly $247 million, after revenue had jumped nearly 50% year over year. It also makes thermo-compression bonding equipment for advanced semiconductor packaging and has been winning AI-related orders from chipmakers, foundries, and packaging houses.
The other two clues are just as distinctive. One company is expanding its independent photomask operation in Allen, Texas, with a more meaningful U.S. contribution expected in 2027. The third reported bookings up 27%, recurring revenue up 25%, a $4.3 billion backlog, and more than 19.4 million computing-enabled endpoints shipped. That is a pretty specific trail.
The stocks behind The AI Survivors
The three stocks are Kulicke and Soffa Industries Inc. (KLIC), Photronics Inc. (PLAB), and Itron Inc. (ITRI). Kulicke and Soffa is the promotion’s headline pick, but the answer is the set.
KLIC is the clearest match. Its fiscal Q2 2026 release guided fiscal Q3 revenue to approximately $310 million, plus or minus $20 million, against consensus estimates of about $246 million. The same release reported revenue of $242.6 million, up from $161.6 million a year earlier. Its annual report and product materials also specifically describe thermocompression systems used in semiconductor assembly, while company announcements tie new orders to AI-related co-packaged optics.
Photronics fits the Texas expansion and independent-photomask clues, while Itron matches the utility digitization numbers almost exactly. Itron’s Q3 2026 release and earnings call cover the 27% bookings growth, 25% recurring-revenue growth, $4.3 billion backlog, and 19.4 million-plus distributed-intelligence-enabled endpoints. The one blemish is Photronics’ promoted $330 million capital-expenditure figure: the company initially estimated that amount for fiscal 2026, then later reduced its guidance to $255 million-$305 million. The expansion is real. The number is stale.
| # | Ticker | Company | Our confidence |
|---|
| Main pick | KLIC | Kulicke and Soffa Industries Inc | 97/100 — high |
| 2 | PLAB |
Do the claims hold up?
The filings and company releases do most of the heavy lifting here. The claim-by-claim checks below separate the statements that line up cleanly with company disclosures from the one figure that has aged badly.
The strongest evidence comes from Kulicke and Soffa’s fiscal Q2 2026 release, Photronics’ fiscal 2025 annual report and fiscal Q2 2026 presentation, and Itron’s Q3 2026 results and earnings call. Those sources make the identification unusually tight.
KLIC — Kulicke and Soffa Industries Inc
| The promotion claims | Verdict | What we found |
|---|
| K&S guided next-quarter revenue to about $310 million. | Checks out | Kulicke & Soffa’s fiscal Q2 2026 release guided fiscal Q3 revenue to approximately $310 million, plus or minus $20 million. |
| Wall Street expected about $247 million for K&S’s next quarter. | Checks out | MarketBeat’s fiscal Q3 2026 estimates listed approximately $246 million of consensus revenue, consistent with the promotion’s roughly $247 million figure. |
|
PLAB — Photronics Inc
| The promotion claims | Verdict | What we found |
|---|
| Photronics is spending about $330 million this year to expand. | Overstated | Photronics’ fiscal 2025 annual report initially estimated fiscal 2026 capital expenditures at approximately $330 million, but later fiscal 2026 guidance reduced the range to $255 million-$305 million; the expansion is real, but the promoted figure is stale and high. |
| Photronics’ expansion includes a new build-out in Allen, Texas. | Checks out | Photronics’ fiscal Q2 2026 investor presentation identified new equipment installation at its Allen, Texas facility and said the site would begin delivering qualification masks. |
|
ITRI — Itron Inc
| The promotion claims | Verdict | What we found |
|---|
| Itron’s latest-quarter bookings rose 27%. | Checks out | Itron’s Q3 2026 financial-results release reported quarterly bookings of $482 million, up 27% year over year. |
| Itron’s recurring revenue grew about 25% in the latest quarter. | Checks out | Itron’s Q3 2026 financial-results release reported annual recurring revenue of $423 million, an increase of 25%. |
|
Where the pitch outran the record
“Photronics is spending about $330 million this year to expand.” — Photronics’ fiscal 2025 annual report initially estimated fiscal 2026 capital expenditures at approximately $330 million, but later fiscal 2026 guidance reduced the range to $255 million-$305 million; the expansion is real, but the promoted figure is stale and high.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
What else they are selling right now
This is the seventh Keith Kohl promotion we’ve identified. Earlier pitches included American Superconductor under “The Prometheus Project,” Matador Resources under “Horseshoe Well,” Recursion Pharmaceuticals under both “Nvidia’s Secret Partner” and “AI Doctor,” IonQ under “The GENESIS MISSION Linchpin,” and NexGen Energy under “The Nuclear Reckoning.”
Since we revealed them, the “AI Doctor” name is up 3.15%, “The GENESIS MISSION Linchpin” is down 6.44%, and “The Nuclear Reckoning” is up 3.79%. That’s context, not a verdict. This is still a small run of identified pitches.
The basket, on its own merits
The pitch’s central claim is simple: AI bubble talk may cool off, but companies supplying real semiconductor equipment, photomasks, and utility infrastructure can outlast the hype.
That chain holds through the first half. Kulicke and Soffa has actual revenue growth, a concrete forward guide, and orders linked to advanced AI packaging. Itron has recurring revenue, a large backlog, rising bookings, and a growing installed base. Those are operating signals, not just a futuristic slogan. Photronics has a real Allen, Texas build-out and a stated path toward more meaningful U.S. revenue in 2027.
The weak link is the phrase “built to outlast.” Current demand doesn’t prove that a company will keep winning if AI spending slows or semiconductor customers change course. Photronics also shows how quickly a clean promotional number can become yesterday’s number: the $330 million capex figure was an earlier estimate, not the company’s later range.
On the merits, KLIC carries the direct AI-packaging thesis, while Itron has the cleanest durability profile because its utility business combines recurring revenue, backlog, and a large deployed base. Photronics is a credible middle case, but its payoff depends more on the Allen expansion ramp. As a basket, these are three different ways to express a real-infrastructure thesis, not three identical bets on AI. The argument survives as a map of businesses with current demand. It doesn’t guarantee they’ll all shrug off the next downturn.
How confident are we? KLIC 97, PLAB 94, ITRI 98 out of 100. We identified 3 stocks from the promotion's own clues and checked 15 claims across them against filings, earnings calls, ownership records, market data and public reporting. Confidence is scored per stock, so a weaker one does not borrow credit from a stronger one. This is our analysis, not the publisher's disclosure — we have no relationship with them.
